The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALLERGAN PLC | SHS | G0177J108 | 167,554 | 1,005,000 | SH | SOLE | 1,005,000 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 51,675 | 2,650,000 | SH | SOLE | 2,650,000 | 0 | 0 | ||
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 59,535 | 1,620,000 | SH | SOLE | 1,620,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 130,608 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 110,680 | 2,000,000 | SH | Call | SOLE | 2,000,000 | 0 | 0 | |
BROOKDALE SENIOR LIVING | COM | 112463104 | 59,085 | 6,500,000 | SH | SOLE | 6,500,000 | 0 | 0 | ||
CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 53,286 | 1,647,677 | SH | SOLE | 1,647,677 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 79,420 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
CLOVIS ONCOLOGY INC | COM | 189464100 | 45,470 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
EAGLE PHARMACEUTICALS INC | COM | 269796108 | 19,755 | 261,100 | SH | SOLE | 261,100 | 0 | 0 | ||
ENDO INTL PLC | SHS | G30401106 | 23,575 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
ENDOLOGIX INC | COM | 29266S106 | 52,638 | 9,300,000 | SH | SOLE | 9,300,000 | 0 | 0 | ||
ENVISION HEALTHCARE CORP | COM | 29414D100 | 72,617 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
GENOMIC HEALTH INC | COM | 37244C101 | 123,888 | 2,458,100 | SH | SOLE | 2,458,100 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS INC | COM | 37890U108 | 99,440 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | ||
HCA HEALTHCARE INC | COM | 40412C101 | 138,510 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
K2M GROUP HLDGS INC | COM | 48273J107 | 45,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
MALLINCKRODT PUB LTD CO | SHS | G5785G107 | 35,454 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 73,400 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 62,475 | 3,055,000 | SH | SOLE | 3,055,000 | 0 | 0 | ||
MYLAN N V | SHS EURO | N59465109 | 90,350 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
MYRIAD GENETICS INC | COM | 62855J104 | 56,055 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 97,660 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
NUVASIVE INC | COM | 670704105 | 62,544 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
PERRIGO CO PLC | SHS | G97822103 | 67,442 | 925,000 | SH | SOLE | 925,000 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 109,720 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 271,280 | 1,000,000 | SH | Put | SOLE | 1,000,000 | 0 | 0 | |
SURGERY PARTNERS INC | COM | 86881A100 | 2,013 | 135,084 | SH | SOLE | 135,084 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 75,533 | 2,250,000 | SH | SOLE | 2,250,000 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 111,175 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 100,296 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 32,450 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 18,475 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 |